Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Nov 1 (Reuters) - NEOVACS SA ALNEV.PA :
* REPORTED ON TUESDAY TOTAL EQUITY OF EUR 49.3 MLN AS OF 30
JUNE
2023
* GROSS FINANCIAL DEBT OF EUR 1.5 MLN AS OF 30 JUNE 2023
* GROSS CASH POSITION OF EUR 6.2 MLN, VS 33 MLN YR AGO
* CASH INVESTMENTS WITH RELATED COMPANIES TOTALLED EUR 16.9
MLN
* H1 OPERATING INCOME AT EUR 3.8 MLN
* END-JUNE NET PROFIT AT EUR 4.3 MLN VS EUR 2.8 MLN AT 30
JUNE
2022
Source text: https://shorturl.at/kmIX4
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants